Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
  1. 4 Open-market sale EVP & Chief Financial Officer sold 3,770 shares at an average $21.38 ($80,615)
  2. 4 Open-market sale EVP, Chief Commercial Officer sold 3,921 shares at an average $21.38 ($83,836)
  3. 4 Open-market sale CEO, President sold 9,352 shares at an average $21.39 ($200,075)
  4. 4 Open-market sale EVP, GC, CCO & Corp Sec sold 2,787 shares at an average $21.40 ($59,653)
  5. 4 Grant or award EVP, Chief Medical Officer acquired 19,717 shares (grant or award)
  6. 4 Grant or award CEO, President acquired 42,300 shares (grant or award)
  7. 4 Grant or award EVP & Chief Financial Officer acquired 19,717 shares (grant or award)
  8. 4 Grant or award EVP, Chief Commercial Officer acquired 19,717 shares (grant or award)
  9. 4 Grant or award EVP, GC, CCO & Corp Sec acquired 19,717 shares (grant or award)
  10. 4 Shares withheld for taxes CEO, President gave up 88,156 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 25,000 shares (grant or award)
  17. 4 Grant or award Director acquired 25,000 shares (grant or award)
  18. 4 Grant or award Director acquired 25,000 shares (grant or award)
  19. 4 Grant or award Director acquired 25,000 shares (grant or award)
  20. 4 Grant or award Director acquired 25,000 shares (grant or award)

Page 4 of 34 · 664 filings